FormWeb • ertugliflozin-metFORMIN

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

ertugliflozin-metFORMIN

ertugliflozin-metFORMIN

Non-formulary
Therapeutic Interchange

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Segluromet	TABLET, ORAL	2.5 mg-500 mg, 2.5 mg-1,000 mg, 7.5 mg-500 mg, 7.5 mg-1,000 mg

Comments:

Segluromet medication guide

Ordered Formulation

Therapeutic Interchnage

ertugflozin-metFORMIN (Segluromet)

2.5 mg-500 mg BID
2.5 mg-1,000 mg BID
7.5 mg-500 mg BID
7.5 mg-1,000 mg BID

ertugliflozin (Steglatro) and metFORMIN (Glucophage)

ONE 5 mg ertugliflozin ONCE daily PLUS 500 mg metFORMIN BID
ONE 5 mg ertugliflozin ONCE daily PLUS 1,000 mg metFORMIN BID
ONE 15 mg ertugliflozin ONCE daily PLUS 500 mg metFORMIN BID
ONE 15 mg ertugliflozin ONCE daily PLUS 1,000 mg metFORMIN BID

Reviewed: 18 Dec 18 (Segluromet)

Last updated: Dec. 20, 2018

Black Box Warning: metFORMIN: Lactic Acidosis

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.